StemCells (STEM) Posts Q1 Results and Data Is Coming, Maxim Group Says
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St ends mixed as oil takes a pause
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
StemCells (STEM) Bullish Stance Reiterated at Maxim Group on Positive Spine Paralysis Data
May 19, 2014 11:57 AM EDTMaxim Group analyst Jason Kolbert reiterated his Buy rating and $2.50 price target on StemCells (NASDAQ: STEM) following positive data on spine paralysis.
Kolbert notes,... More
Stemcells (STEM) Posts Mixed Q1 Results
May 14, 2014 4:02 PM EDTStemcells (NASDAQ: STEM) reported Q1 EPS of ($0.14), $0.02 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $339 thousand versus the consensus estimate of $240 thousand.
For earnings history and earnings-related data on Stemcells (STEM) click here.
... More